Health News Releases

September 23, 2021 16:10

Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches

Boehringer Ingelheim today announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology research to develop the n

September 23, 2021 16:00

Clinical Investigation Shows Herb-Pharma's ViroStop Spray Effective in Reducing Impact of Covid-19

A recent clinical study has shown that the ViroStop anti-viral spray from Swiss company, Herb-Pharma is effective in reducing the impact of Covid-19 for patients with mild to moderate symptoms. The

September 23, 2021 13:30

Hologic Releases Results of Inaugural Global Women’s Health Index - First Study Representing the Health of 2.5 Billion Women and Girls

Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, today shared the findings from its inaugural Hologic Global Women’s Health Index, the world’s most comprehensive, globally comparative

September 17, 2021 14:45

Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock

Virpax® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the closing of an underwritten

September 17, 2021 13:35

Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS™ (sotorasib), a KRASG12C Inhibitor

Boehringer Ingelheim today announced a clinical phase I collaboration with Amgen to evaluate the combination of BI 1701963, the first and most advanced SOS1::pan-KRAS inhibitor exhibiting activity aga

September 17, 2021 11:40

Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the companies have entered into a joint collaboration

September 17, 2021 11:30

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

Global healthcare data technology company, Prospection, has successfully raised $45 million from institutional investors in a Series B round, cornerstoned by new investor Ellerston JAADE with particip

September 17, 2021 11:15

Takeda’s EXKIVITY™ (mobocertinib) Approved by U.S. FDA as the First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has approved EXKIVITY (mobocertinib) for the treatment of adult pa

September 16, 2021 14:15

Trividia Health Announces Jonathan Chapman as President and Chief Executive Officer

Trividia Health, Inc., a leading supplier of blood glucose monitoring systems, announced today that Jonathan Chapman has been appointed as President and Chief Executive Officer. Mr. Chapman succeeds S

September 16, 2021 09:30

Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock

Virpax® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of an underwritten

September 15, 2021 14:10

Charles Taylor Launches Guardian Managed Care Solutions, a Medical Bill Review Company

Charles Taylor is pleased to announce the launch of Guardian Managed Care Solutions, a medical bill review company, providing cost containment services for employers, third party administrators (TPAs)

September 14, 2021 14:30

Masimo Launches Single-patient-use rainbow® SuperSensor™

Masimo (NASDAQ: MASI) announced today the CE marking and commercial launch in Europe of the single-patient-use adhesive rainbow® SuperSensor™, compatible for use with both Masimo and third-party monit

September 14, 2021 10:20

ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical

ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR), a medical device and digital healt

September 13, 2021 10:30

Merck to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021

Merck, a leading science and technology company, today announced research from Company-sponsored, investigator-sponsored, and collaborative studies — including two oral and two mini-oral presentations

September 10, 2021 15:50

Galderma to Present New Data From Leading Aesthetics Portfolio and Launch* RESTYLANE® EYELIGHT™ at AMWC 2021

Galderma today announced new results from its robust pipeline and portfolio of dermal fillers and toxin injections. Eleven e-posters from Galderma-sponsored and investigator-initiated trials have been

September 10, 2021 15:30

Empagliflozin receives Breakthrough Therapy Designation in U.S. for heart failure with preserved ejection fraction (HFpEF)

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for empagliflozin as an investigational treatment for adults with heart failure with preserved ejection fractio

September 10, 2021 15:15

Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based researc

September 09, 2021 17:10

Speed Medical SAE, Secures EGP 1.57 Billion Capital Commitment from Global Emerging Markets (GEM)

Speed Medical Company (EGX: SPMD), today announced a EGP 1.57 billion capital commitment from GEM Global Yield LLC SCS (“GGY”), the Luxembourg based private alternative investment group. Under the

September 08, 2021 17:30

Hyperice Enters Next Stage of Global Growth; Evolves Into a Holistic High-Performance Wellness Brand

Over the last ten years, Hyperice has worked tirelessly to push the boundaries of innovation to help better serve athletes everywhere. Today, the company announced a new stage of global growth as the

September 07, 2021 14:55

New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients

Masimo (NASDAQ: MASI) announced today the findings of a prospective, blinded observational study published in Annals of Intensive Care in which Dr. Jean-Baptiste Lascarrou and colleagues at the Centre

September 03, 2021 15:45

Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use

Invivoscribe, Inc., a technology-driven international company focused on precision diagnostics with best-in-class products and services that optimize patient care and accelerate drug approvals worldwi

September 02, 2021 16:10

Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the Phase 3 PANTHER (Pevonedistat-3001) study did not achieve pre-defined statistical significance for the pri

September 01, 2021 17:50

Patient Safety Movement Foundation Calls for Action in Advance of Second Annual #UniteForSafeCare Event

The second annual #UniteForSafeCare event is scheduled for Friday, September 17th in conjunction with World Patient Safety Day. The event is hosted by the Patient Safety Movement Foundation (PSMF) and

September 01, 2021 16:00

Morinaga Milk Reveals Major Breakthroughs in a ‘Bifidobacteria Training’ Program With Professional Footballer Yuto Nagatomo

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a pioneer in bifidobacteria and gut microbiota research, reveals that its collaborative ‘Bifidobacteria Training’ project (launched in June 2020) helped

September 01, 2021 11:40

Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose

To mark International Overdose Awareness Day (IOAD) on August 31, Masimo (NASDAQ: MASI), a global medical technology company, announced today its commitment to raising awareness of the risks of overdo

News by Region

News by Industry